8:50am ET
Health and Healthcare
Major Biotech Short Interest Surges
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Companies
/Healthcare
Gilead Sciences Inc
$146.64
▼ $4.36 (−2.88%) today
Markets closed · 5:30am ET
GILD Coverage
Page 22
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More
The top analyst upgrades, downgrades and other research calls from Friday include AK Steel, Altice USA, Biogen, Caterpillar, Gilead Sciences and Oracle.
9:40am ET
Health and Healthcare
Short Interest Surges in Major Biotechs
The May 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
9:50am ET
Health and Healthcare
Short Sellers Raise the Stakes in Major Biotechs
The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
11:40am ET
Health and Healthcare
Why Big Pharma Is Not at Fault for Record Drug Spending
With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it as the industry punching bag.
10:40am ET
Health and Healthcare
Major Biotech Short Interest Remains Mixed
The April 28 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
11:10am ET
Health and Healthcare
Gilead Faces Serious Conundrum: Value Trap vs Real Value
Many value investors have flocked to Gilead Sciences as the world's top biotech stock now that it is valued at a lower multiple than Big Pharma rivals.
Jon C. Ogg 7:55am ET
Investing
Value or Value Trap: Meet the 21 S&P 500 Stocks Valued Under 10 Times Earnings
As of the start of May of 2017, just 21 members of the S&P 500 Index were valued at less than 10 times expected earnings per share.
9:40am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Biotechs
The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
9:20am ET
Investing
Analysts See 10 Companies Beating Expectations This Earnings Season
With earnings starting to really snowball next week, and a market that seems to be teetering somewhat due to high valuations and some messy geopolitical issues, it makes sense for investors to…
9:10am ET
Health and Healthcare
Short Sellers Back Off Major Biotechs
The March 31 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
9:50am ET
Health and Healthcare
Jefferies Thinks 3 Red-Hot Biotech Stocks Can Beat Q1 Estimates
A massive new Jefferies research report reminds investors that as a rule the first quarter is traditionally slower for biotechnology stocks.
10:30am ET
Health and Healthcare
Short Interest Pulls Back in Major Biotechs
The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of the ACA fell through, the health care rally is called into question.
9:15am ET
Health and Healthcare
How Health Care Stocks Responded to the Shelved Health Care Bill
24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen a reaction from the health care vote in Congress, or lack thereof.
9:50am ET
Health and Healthcare
Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now
These are four top stocks to buy in a sector that has much more value than many on Wall Street. All are rated Buy at Jefferies and have outstanding upside potential.